<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JCI Insight</journal-id>
<journal-id journal-id-type="iso-abbrev">JCI Insight</journal-id>
<journal-id journal-id-type="publisher-id">JCI Insight</journal-id>
<journal-title-group>
<journal-title>JCI Insight</journal-title>
</journal-title-group>
<issn pub-type="epub">2379-3708</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29202453</article-id>
<article-id pub-id-type="pmc">5752375</article-id>
<article-id pub-id-type="publisher-id">95512</article-id>
<article-id pub-id-type="doi">10.1172/jci.insight.95512</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Increased Ca<sup>2+</sup> signaling through Ca<sub>V</sub>1.2 promotes bone formation and prevents estrogen deficiency–induced bone loss</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cao</surname>
<given-names>Chike</given-names>
</name>
<email>chc2076@med.cornell.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3361-6015</contrib-id>
<name>
<surname>Ren</surname>
<given-names>Yinshi</given-names>
</name>
<email>yinshi.ren@dm.duke.edu</email>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barnett</surname>
<given-names>Adam S.</given-names>
</name>
<email>adam.barnett@dm.duke.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mirando</surname>
<given-names>Anthony J.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rouse</surname>
<given-names>Douglas</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mun</surname>
<given-names>Se Hwan</given-names>
</name>
<email>MunS@HSS.EDU</email>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park-Min</surname>
<given-names>Kyung-Hyun</given-names>
</name>
<email>parkmink@hss.edu</email>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McNulty</surname>
<given-names>Amy L.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7380-0330</contrib-id>
<name>
<surname>Guilak</surname>
<given-names>Farshid</given-names>
</name>
<email>guilak@wustl.edu</email>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Karner</surname>
<given-names>Courtney M.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hilton</surname>
<given-names>Matthew J.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2246-0289</contrib-id>
<name>
<surname>Pitt</surname>
<given-names>Geoffrey S.</given-names>
</name>
<email>geoffrey.pitt@med.cornell.edu</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Ion Channel Research Unit, Duke University Medical Center, Durham, North Carolina, USA.</aff>
<aff id="A2"><label>2</label>Cardiovascular Research Institute, Weill Cornell Medicine, New York, New York, USA.</aff>
<aff id="A3"><label>3</label>Department of Orthopaedic Surgery and</aff>
<aff id="A4"><label>4</label>Department of Lab Animal Resources &amp; Rodent Surgical and Genetic Services, Duke University Medical Center, Durham, North Carolina, USA.</aff>
<aff id="A5"><label>5</label>Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, New York, USA.</aff>
<aff id="A6"><label>6</label>Department of Orthopaedic Surgery, Washington University Medical Center, St. Louis, Missouri, USA.</aff>
<aff id="A7"><label>7</label>Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, USA.</aff>
<author-notes>
<corresp>Address correspondence to: Matthew J. Hilton, 308 Research Drive, LSRC Building Room B321C, Duke University, Durham, North Carolina 27708, USA. Phone: 919.613.9761; Email: <email>matthew.hilton@dm.duke.edu</email>. Or to: Geoffrey S. Pitt, 413 East 69th Street, Belfer Research Building Room 502, Weill Cornell Medicine, New York, New York 10021, USA. Phone: 646.962.7641; Email: <email>geoffrey.pitt@med.cornell.edu</email>.</corresp>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> The authors have declared that no conflict of interest exists.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2017-11-16T09:00:00-0500" publication-format="electronic">
<day>16</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2017-11-16T09:00:00-0500" publication-format="electronic">
<day>16</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>16</day>
<month>11</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 0 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>2</volume>
<issue>22</issue>
<elocation-id>e95512</elocation-id>
<history>
<date date-type="received">
<day>5</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017, American Society for Clinical Investigation</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://insight.jci.org/articles/view/95512">This article is available online at https://insight.jci.org/articles/view/95512</self-uri>
<abstract>
<p>While the prevalence of osteoporosis is growing rapidly with population aging, therapeutic options remain limited. Here, we identify potentially novel roles for Ca<sub>V</sub>1.2 L-type voltage–gated Ca<sup>2+</sup> channels in osteogenesis and exploit a transgenic gain-of-function mutant Ca<sub>V</sub>1.2 to stem bone loss in ovariectomized female mice. We show that endogenous Ca<sub>V</sub>1.2 is expressed in developing bone within proliferating chondrocytes and osteoblasts. Using primary BM stromal cell (BMSC) cultures, we found that Ca<sup>2+</sup> influx through Ca<sub>V</sub>1.2 activates osteogenic transcriptional programs and promotes mineralization. We used <italic>Prx1-</italic>, <italic>Col2a1-</italic>, or <italic>Col1a1-Cre</italic> drivers to express an inactivation-deficient Ca<sub>V</sub>1.2 mutant in chondrogenic and/or osteogenic precursors in vivo and found that the resulting increased Ca<sup>2+</sup> influx markedly thickened bone not only by promoting osteogenesis, but also by inhibiting osteoclast activity through increased osteoprotegerin secretion from osteoblasts. Activating the Ca<sub>V</sub>1.2 mutant in osteoblasts at the time of ovariectomy stemmed bone loss. Together, these data highlight roles for Ca<sub>V</sub>1.2 in bone and demonstrate the potential dual anabolic and anticatabolic therapeutic actions of tissue-specific Ca<sub>V</sub>1.2 activation in osteoblasts.</p>
</abstract>
<abstract abstract-type="toc">
<p>Ca<sub>V</sub>1.2 regulates bone development, and a transgenic gain-of-function mutant Ca<sub>V</sub>1.2 stems bone loss in ovariectomized female mice.</p>
</abstract>
<kwd-group kwd-group-type="specialties">
<kwd>Bone Biology</kwd>
</kwd-group>
<kwd-group kwd-group-type="keywords">
<kwd>Bone development</kwd>
<kwd>Calcium channels</kwd>
<kwd>Osteoclast/osteoblast biology</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>